17 related articles for article (PubMed ID: 21956355)
1. Powerful anti-colon cancer effect of modified nanoparticle-mediated IL-15 immunogene therapy through activation of the host immune system.
Liu X; Li Y; Sun X; Muftuoglu Y; Wang B; Yu T; Hu Y; Ma L; Xiang M; Guo G; You C; Gao X; Wei Y
Theranostics; 2018; 8(13):3490-3503. PubMed ID: 30026861
[No Abstract] [Full Text] [Related]
2. Efficient Colon Cancer Immunogene Therapy Through Co-Delivery of IL-22BP mRNA and Tumor Cell Lysate by CLSV Nanoparticles.
Huang J; Wang K; Fu X; Zhu M; Chen X; Gao Y; Ma P; Duan X; Men K
Int J Nanomedicine; 2023; 18():8059-8075. PubMed ID: 38164262
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer.
Morris JC; Ramlogan-Steel CA; Yu P; Black BA; Mannan P; Allison JP; Waldmann TA; Steel JC
Gene Ther; 2014 Apr; 21(4):393-401. PubMed ID: 24572789
[TBL] [Abstract][Full Text] [Related]
4. Amplified interleukin-15 expression vectors for cancer immunogene therapy.
He X; Li W; Lu N; Qi F; Zhao N; Qiu Y; Zhu L
Mol Med Rep; 2008; 1(3):369-74. PubMed ID: 21479419
[TBL] [Abstract][Full Text] [Related]
5. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence.
Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M
Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497
[TBL] [Abstract][Full Text] [Related]
6. Tumor secreting high levels of IL-15 induces specific immunity to low immunogenic colon adenocarcinoma via CD8+ T cells.
Araki A; Hazama S; Yoshimura K; Yoshino S; Iizuka N; Oka M
Int J Mol Med; 2004 Oct; 14(4):571-6. PubMed ID: 15375583
[TBL] [Abstract][Full Text] [Related]
7. Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity.
Stephenson KB; Barra NG; Davies E; Ashkar AA; Lichty BD
Cancer Gene Ther; 2012 Apr; 19(4):238-46. PubMed ID: 22158521
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of colon tumor growth by IL-15 immunogene therapy.
He X; Li W; Wang Y; Hou L; Zhu L
Mol Med Rep; 2012 Jan; 5(1):96-102. PubMed ID: 21956355
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
